Quantcast
business-standard.com 14 May, 2022 11:30 am

Sputnik Light manufacturer unable to sell stock, urges Modi for procurement

Sputnik Light manufacturer unable to sell stock, urges Modi for procurement
Read more about Sputnik Light manufacturer unable to sell stock, urges Modi for procurement on Business Standard. Unable to sell its huge stock of Covid vaccine Sputnik Light amid the Russia-Ukraine conflict, the Bengaluru-based Stelis Biopharma has written to PM Modi requesting for procurement of the jabs

Sputnik Light manufacturer unable to sell stock, urges Modi for procurement Unable to sell its huge stock of Covid vaccine Sputnik Light amid the Russia-Ukraine conflict, the Bengaluru-based Stelis Biopharma has written to PM Modi requesting for procurement of the jabs strong Narendra Modi | Coronavirus Vaccine Press Trust of India  | New Delhi Last Updated at May 14, 2022 16:15 IST Kumar requested that the government should acquire the available doses, failing which these will get wasted and the company will face a huge financial loss.ALSO READ Delhi govt's response sought in plea against mandatory Covid vaccine jabs Sputnik V, Sputnik Light will neutralise new Covid variant Omicron: Russia Wheat procurement down 44% to 162 lakh tonnes till May 1 on higher exports NTAGI allows 1st dose as booster for those vaccinated with Sputnik: Report Govt panel recommends EUA for single-dose Covid jab Sputnik Light Unable to sell its huge stock of Covid vaccine Sputnik Light amid the Russia-Ukraine conflict, the Bengaluru-based Stelis Biopharma has written to Prime Minister Narendra Modi requesting for procurement of the jabs for inoculating citizens here or supplying to other countries under the Vaccine Maitri programme.The Drugs Controller General of India (DCGI) had granted emergency use permission to Sputnik Light, subject to certain regulatory provisions, in February this year.In the letter written on May 13, Arun Kumar, Founder and Director of Stelis Biopharma Limited, said that after the prime minister had requested the industry to gear up to tackle the pandemic, the firm invested over Rs 700 crore to set up a state-of the-art vaccine manufacturing facility within six months despite the COVID-19-induced restrictions and quickly commenced the production of Sputnik Light.

"We are proud to state that after having been granted due approvals by the Government of India, we started manufacturing Sputnik Light in India and produced no less than 2.Sputnik Light is a one-dose vaccine and is same as component-1 of Sputnik V.

Read full story at business-standard.com